We have just learned that capreomycin is not available. Akorn (sole manufacturer of Capreomycin) indicated that the drug is on back order (not available) and there is no release date information (no estimate of when it will become available). This information is not yet reported on the FDA website but the California Department of Public Health TB program reported this to our contacts at FDA last week.
If you have individuals who require this drug for their current treatment regimen, please remember to report any shortages/impact for your program and those you care for into the online NTCA drug shortage reporting form. These reports, provided in real-time, give us critical information for our federal partners and at the manufacturers about the extensiveness of these supply interruptions and the impact on quality patient care.
Please direct any questions to email@example.com or report a shortage right away using this website: http://www.surveygizmo.com/s3/1456841/TB-Drugs-Diagnostics-Shortages-Reporting-Form